Neuro-Oncology Reviews
Volume
28 Number 21
31 July 2026
Home > Publications > Neuro-Oncology Reviews > Volume 28, Year 2026 > Number 21, 31 July
Jia M, Cui G, Liu Z, Luo C.
Bibliometric
analysis of programmed cell death and immunotherapy research in
glioma.
Discov
Oncol. 2026 Jul 21. doi:
10.1007/s12672-026-05535-7. PMID:
42481885. ˍ
Wang C, Sun Z, Sun J, Liu J, Zhao Q, Sun Y, Sun C.
Tumor
microenvironment-responsive nanocarriers for enhanced glioblastoma
immunotherapy.
J
Nanobiotechnology. 2026 Jul 21. doi:
10.1186/s12951-026-04823-2. PMID:
42482062. ˍ
Bryukhovetskiy I, Pak O, Polevshchikov A.
Glioblastoma
stem cells as carriers of tumour memory: a strategy for
personalised immunotherapy using tumour-infiltrating lymphocytes.
Front
Immunol. 2026 Jul 22;17:1880908. doi:
10.3389/fimmu.2026.1880908. PMID:
42558850. ˍ
Chang SM, Huang MAC, Barbour M.
Pediatric
Brain Tumors.
Adv
Pediatr. 2026 May 22;73(1):269-282. doi:
10.1016/j.yapd.2025.11.002. PMID:
42481096˰ ˍ
Etter MM, Akeret K, Guzman R, Mariani L, Hutter G, Lim M.
Recent
Locoregional CAR T-Cell Trials for the Treatment of Recurrent
Glioblastoma: Implications for Neuro-Oncology Practice.
CNS
Drugs. 2026 Jul 22. doi:
10.1007/s40263-026-01322-8. PMID:
42486970. ˍ
Vershinina O, Turubanova V, Franceschi C, Ivanchenko M.
Towards
a personalized perspective on gliomas: an
epigenetic-immuno-inflammatory aging framework.
Front
Immunol. 2026 Jul 22;17:1898095. doi:
10.3389/fimmu.2026.1898095. PMID:
42558471. ˍ
Wen W, Zhang Z, Wang Y, Zhu G, Zhang Q.
Reprogramming
the vascular-immune niche: Towards a new therapeutic paradigm for
glioblastoma.
Crit
Rev Oncol Hematol. 2026 Jul 23;226:105500. doi:
10.1016/j.critrevonc.2026.105500. PMID:
42492866˰ ˍ
Sarma RK, Nath P, Bora P, Chetia P, Bala A.
Advancing
chimeric antigen receptor T-cell therapy frontiers in
glioblastoma: Navigating the current landscape from clinical
hurdles to breakthrough strategies.
Int
Immunopharmacol. 2026 Jul 24;187:117134. doi:
10.1016/j.intimp.2026.117134. PMID:
42497658˰ ˍ
Darko K, Tenkorang P, Osei-Tutu GJ, Asiedu O, Tahiru M,
Nkrumah-Boateng P, Chen J, Fonkem E, Etame AB.
Vaccine-based
cancer immunotherapy in newly diagnosed glioblastoma: a
time-to-event meta-analysis of phase II and III randomized
controlled trials.
Clin
Transl Oncol. 2026 Jul 25. doi:
10.1007/s12094-026-04514-2. PMID:
42501205˰ ˍ
Filiberti S, Tavani C, Somenza E, Tassone N, d'Amati A, Turati M,
Ronca R.
The FGF/FGFR System in the
Biology and Therapeutic Landscape of Pediatric CNS Tumors.
Med
Res Rev. 2026 Jul 25. doi:
10.1002/med.70090. PMID:
42499273. ˍ
Mohammed Aleid A, Abdullah Houlbah I, Yahya Abutaleb M, Mohammed
Hakami M, Ali M Alshahrani F, Khalid Aldawsari S, Ahmed Salem
Algethmi R, Abdulrahman Ismail A, Fadhel Almalki S.
Dendritic
Cell Vaccines for Glioblastoma: A Systematic Review and
Meta-Analysis Comparing New-Onset and Recurrent Cases.
Anticancer
Agents Med Chem. 2026 Jul 27. doi:
10.2174/0118715206406017251124090916. PMID:
42565415. ˍ
Ramirez-Ferrer E, Noll K, Mayorga-Corvacho J, Sierra MA, Furey C,
Bugarini A, Zuluaga-Garcia JP, Asman P, Ene C, Ferguson SD,
Weinberg JS, Lang FF, Duffau H, Prabhu SS.
Beyond
motor: clinical manifestations of right hemisphere gliomas - a
systematic review.
J
Neurooncol. 2026 Jul 27;179(1):15. doi:
10.1007/s11060-026-05728-8. PMID:
42507250. ˍ
Guarnaccia M, Cavallaro S.
The Price
of Precision: A Critical Review of Molecular Diagnostics in
Glioma, From Guidelines to Global Disparities.
Ann
Clin Transl Neurol. 2026 Jul 28:10.1002/acn3.70503.
doi:
10.1002/acn3.70503. PMID:
42516044. ˍ
Monje M.
The neuroscience of childhood
brain cancers.
Sci
Transl Med. 2026 Jul 29;18(860):eaeg9138. doi:
10.1126/scitranslmed.aeg9138. PMID:
42525784˰ ˍ
Onyekweli SO, Omoruyi GO, Akintayo CO, Olaniyi SK.
Engineering
CAR-T cells for solid tumors: Overcoming the microenvironment
through integrated design and clinical translation.
Oncoscience.
2026 Jul 29;13:227-249. doi:
10.18632/oncoscience.666. PMID:
42540518. ˍ
Pasvolsky L, Jones GH, Vu Y, Winkler F, Amit M.
Cancer
neuroscience: Mechanisms to medicine.
Sci
Transl Med. 2026 Jul 29;18(860):eaeh1718. doi:
10.1126/scitranslmed.aeh1718. PMID:
42525788. ˍ
Villa GR, Patel AD, Reardon DA, Chiocca EA.
Glioblastoma:
Overcoming fundamental biological and delivery barriers to
therapy.
Sci
Transl Med. 2026 Jul 29;18(860):eaeg8772. doi:
10.1126/scitranslmed.aeg8772. PMID:
42525786. ˍ